In the news (110):
Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals -
Trade group sues FDA over ending Mounjaro/Zepbound shortage -
FDA says shortage ends for Eli Lilly weight loss and diabetes drug -
FDA Approves Potentially Groundbreaking Schizophrenia Drug
Summary
The company Fda.Jp is from Japan.
Business
Fda.Jp is one of the companies in Japan. Fda.Jp is one of the 3,466,499 companies in our database.
Stocks from Fda. Jp
Explore more on business
Talking Points:
- NPO FDA
- We have created a new FDA page with our Facebook business account.
Learn more about talking points